Bioceres Crop Solutions Corp. (Form: 6-K, Received: 10/28/2020 17:06:17)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rules 13a-16 or 15d-16 under

the Securities Exchange Act of 1934

Dated October 28, 2020

Commission File Number: 001-38836

BIOCERES CROP SOLUTIONS CORP.

(Translation of registrant’s name into English)

Ocampo 210 bis, Predio CCT, Rosario

Province of Santa Fe, Argentina

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F x Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

EXPLANATORY NOTE

This Form 6-K (including the exhibit) is incorporated by reference into the Company’s registration statement on Form F-3 (Registration No. 333-237496), and the following exhibit is filed as part of this Form 6-K:

Exhibit List

Exhibit No.		Description
99.1		Press release, Annual Shareholders’ Meeting dated October 28, 2020

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		BIOCERES CROP SOLUTIONS CORP.
		(Registrant)


Dated: October 28, 2020	By:	By:	/s/ Federico Trucco
		Name:	Federico Trucco
		Title:	Chief Executive Officer

EXHIBIT 99.1

Bioceres Crop Solutions Corp. Holds its 2020 Annual Shareholders’ Meeting

New York, New York / October 28, 2020 - Bioceres Crop Solutions Corp. (“Bioceres Crop Solutions,” the “Company,” “we,” “us” or “our”) (NYSE American: BIOX) held its 2020 Annual Shareholders’ Meeting (the “Meeting”) at the Company’s legal counsel’s office in New York, NY and virtually. At the Meeting, the Company’s shareholders voted on four proposals as set forth below, each of which is described in detail in the proxy statement filed by the Company on October 1^st, 2020. Each of the four proposals were approved at the Meeting by a simple majority of the shareholders who voted at the Meeting (either in person or by proxy).

Approval of the report of the Board of Directors of the Company, the report of the independent auditor on the Company’s consolidated financial statements for the financial year ended June 30, 2020 and the Company’s consolidated financial statements for the fiscal year ended June 30, 2020.

Establishment of supplemental equity compensation and purchase plan for up to 300,000 ordinary shares.

Appointment of the following persons to serve as directors of the Company, each to hold office until the 2021 annual general meeting of the Company or until their respective successors are duly appointed and qualified: (i) Federico Trucco; (ii) Enrique Lopez Lecube; (iii) Kyle Bransfield; (iv) Gloria Montaron Estrada; (v) Carlos Camargo de Colón; (vi) Ari Freisinger; and (vii) Natalia Zang.

Ratification of the appointment of Price Waterhouse & Co. S.R.L. as the independent registered public accounting firm of the Company.